These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [A continuous experience of the use of norethindrone-ethinyl estradiol combination in small doses as a contraceptive]. Ruíz Moreno JA, Rubio Lotvin B, Bolio Arista R, de Larios NM. Ginecol Obstet Mex; 1977 Feb; 41(244):179-84. PubMed ID: 321297 [Abstract] [Full Text] [Related]
3. Clinical and laboratory experience with a modified low dosage sequential oral contraceptive. Wamsteker EF. Int J Fertil; 1968 Feb; 13(4):436-43. PubMed ID: 5700403 [No Abstract] [Full Text] [Related]
4. Evaluation of a low-dose oral contraceptive pill for primary dysmenorrhea: a placebo-controlled, double-blind, randomized trial. Harada T, Momoeda M, Terakawa N, Taketani Y, Hoshiai H. Fertil Steril; 2011 May; 95(6):1928-31. PubMed ID: 21420678 [Abstract] [Full Text] [Related]
8. A report of a collaborative dose-response clinical study using decreasing doses of combination oral contraceptives. Preston SN. Contraception; 1972 Jul; 6(1):17-35. PubMed ID: 4659582 [No Abstract] [Full Text] [Related]
9. [Longterm study of a minipill consisting of 30 mcg ethinyl estradiol and 1 mg norethisterone acetate]. Cohen J, Crouzette J. Contracept Fertil Sex (Paris); 1976 Mar; 4(2):111-4. PubMed ID: 1261725 [No Abstract] [Full Text] [Related]
10. A report of the correlation between the pregnancy rates of low estrogen formulations and pill-taking habits of females studied. Preston SN. J Reprod Med; 1974 Aug; 13(2):75-7. PubMed ID: 4844518 [No Abstract] [Full Text] [Related]
13. Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents. Molina RC, Sandoval JZ, Montero AV, Oyarzún PG, Molina TG, González EA. J Pediatr Adolesc Gynecol; 2009 Feb; 22(1):25-31. PubMed ID: 19232299 [Abstract] [Full Text] [Related]
14. The choice of the dose of oestrogen in a combined oral contraceptive. Smith M. Fertil Contracept; 1978 Apr; 2(2):22-3. PubMed ID: 12336093 [Abstract] [Full Text] [Related]
15. Multicenter randomized comparative trial of two low-dose triphasic combined oral contraceptives containing desogestrel or norethindrone. Shoupe D. Obstet Gynecol; 1994 May; 83(5 Pt 1):679-85. PubMed ID: 8164925 [Abstract] [Full Text] [Related]
16. [Oral hormonal contraception with Depositon]. Göretzlehner G, Rudolf K, Klausch B, Straube W, Hofmann R. Dtsch Gesundheitsw; 1975 Aug 02; 30(33):1553-8. PubMed ID: 1192950 [No Abstract] [Full Text] [Related]
17. Malignant hypertension, uremia and hemolytic anemia in a patient on oral contraceptives. Tobon H. Obstet Gynecol; 1972 Nov 02; 40(5):681-5. PubMed ID: 5083217 [No Abstract] [Full Text] [Related]
18. The incidence of side-effects with a low-oestrogen contraceptive pill. Boffa PS. Practitioner; 1971 Feb 02; 206(232):263-5. PubMed ID: 5554563 [No Abstract] [Full Text] [Related]
19. Fertility limitation through contraceptive steroids in the People's Republic of China. Djerassi C. Stud Fam Plann; 1974 Jan 02; 5(1):13-30. PubMed ID: 4810445 [No Abstract] [Full Text] [Related]
20. [Ovulation inhibition with low dosage gestagen components. Results of international clinical trial of Orlest]. Figoureux J, Onghena G, Schlikker E, Wattiez M, Schlösser W, Vercautere E, William P. Munch Med Wochenschr; 1967 Dec 01; 109(48):2555-8. PubMed ID: 5631905 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]